New candidate biomarkers in the female genital tract to evaluate microbicide toxicity

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Fields, Scott ^a   Song, Benben ^a   Rasoul, Bareza ^a   Fong, Julie ^a   Works, Melissa G ^a   Shew, Kenneth ^a   Yiu, Ying ^a   Mirsalis, Jon ^a   D'Andrea, Annalisa ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANTERIOR GRADIENT PROTEIN 2; BENZALKONIUM CHLORIDE; BIOLOGICAL MARKER; FIBRINOGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MICROBICIDE; MONOCYTE CHEMOTACTIC PROTEIN 3; NONOXINOL 9; OLFACTOMEDIN 4; PLASMINOGEN; RANTES; TENOFOVIR; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BENZALKONIUM; CELLULOSE; CELLULOSE SULFATE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; MUC5B PROTEIN, MOUSE; MUCIN 5B; NONOXINOL; OLFM4 PROTEIN, HUMAN; PGLYRP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE GENITAL SYSTEM; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; UPREGULATION; VAGINA; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; RABBIT;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-INFECTIVE AGENTS; BENZALKONIUM COMPOUNDS; BIOMARKERS; CELLULOSE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GENITALIA, FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HIV INFECTIONS; HUMANS; MICE; MUCIN-5B; NONOXYNOL; RABBITS; VAGINA;

EID: 84908191502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110980     Document Type: Article

References (55)

1. Catalone B, Kish-Catalone T, Neely E., Budgeon L, Ferguson M, et al (2005) Comparative safety evaluation of the candidate vaginal microbicide C31G. Antimicrob Agents Chemother 49: 1509-1520.
2. Catalone BJ, Miller SR, Ferguson M.L., Malamud D., Kish-Catalone T, et al. (2005) Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. Biomed Pharmacother 59: 430-437.
3. Cohen J (2008) AIDS research. Microbicide fails to protect against HIV. Science 319: 1026-1027.
4. Cone R, Hoen T, Wong X., Abusuwwa R, Anderson D, et al (2006) Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infectious Diseases 6: 90.
5. Fichorova R, Tucker L, Anderson D. (2001) The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184: 418-428.
6. Honey K (2007) Microbicide trial screeches to a halt. J Clin Invest 117: 1116.
7. Kreiss J, Ngugi E, Holmes K., Ndinya-Achola J, Waiyaki P, et al (1992) Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 268: 477-482.
8. Mayer KH, Peipert J, Fleming T., Fullem A, Moench T, et al (2001) Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis 32: 476-482.
9. Roddy RE, Zekeng L, Ryan K.A., Tamoufe U., Weir SS, et al. (1998) A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 339: 504-510.
10. Skoler-Karpoff S., Ramjee G, Ahmed K., Altini L, Plagianos MG, et al (2008) Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. The Lancet 372: 1977-1987.
11. Van Damme L., Chandeying V, Ramjee G., Rees H, Sirivongrangson P, et al (2000) Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group. AIDS 14: 85-88.
12. Van Damme L., Govinden R, Mirembe F.M., Guédou F, Solomon S., et al. (2008) Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission. New England Journal of Medicine 359: 463-472.
13. Van Damme L., Ramjee G, Alary M., Vuylsteke B, Chandeying V, et al (2002) Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360: 971-977.
14. Kish-Catalone T.M., Lu W, Gallo R.C., DeVico A.L. (2006) Preclinical evaluation of synthetic-2 RANTES as a candidate vaginal microbicide to target CCR5. Antimicrob Agents Chemother 50: 1497-1509.
15. Zeitlin L, Hoen TE, Achilles S.L., Hegarty TA, Jerse AE, et al. (2001) Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis 28: 417-423.
16. Kaminsky M, Szivos MM, Brown K.R., Willigan D.A. (1985) Comparison of the sensitivity of the vaginal mucous membranes of the albino rabbit and laboratory rat to nonoxynol-9. Food Chem Toxicol 23: 705-708.
17. Tien D, Schnaare RL, Kang F, Cohl G., McCormick TJ, et al. (2005) In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses 21: 845-853.
18. Alt C, Harrison T, Dousman L., Fujita N, Shew K, et al (2009) Increased CCL2 expression and macrophage/monocyte migration during microbicide-induced vaginal irritation. Curr HIV Res 7: 639-649.
19. Fichorova RN, Bajpai M, Chandra N., Hsiu JG, Spangler M, et al. (2004) Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod 71: 761-769.
20. Anderson RA, Feathergill KA, Diao X.H., Cooper MD, Kirkpatrick R, et al. (2002) Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent. J Androl 23: 426-438.
21. Kurita T (2010) Developmental origin of vaginal epithelium. Differentiation 80: 99-105.
22. Barberini F, Correr S, De Santis F, Motta P.M. (1991) The epithelium of the rabbit vagina: a microtopographical study by light, transmission and scanning electron microscopy. Arch Histol Cytol 54: 365-378.
23. Costin GE, Raabe HA, Priston R, Evans E., Curren R.D. (2011) Vaginal irritation models: the current status of available alternative and in vitro tests. Altern Lab Anim 39: 317-337.
24. Achilles SL, Shete PB, Whaley K.J., Moench TR, Cone R.A. (2002) Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 29: 655-664.
25. Cone RA, Hoen T, Wong X., Abusuwwa R, Anderson DJ, et al (2006) Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis 6: 90.
26. Catalone BJ, Kish-Catalone TM, Budgeon L.R., Neely EB, Ferguson M, et al. (2004) Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob Agents Chemother 48: 1837-1847.
27. Milligan G, Dudley K, Bourne N., Reece A, Stanberry L. (2002) Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis 29: 597-605.
28. Achilles S, Shete P, Whaley K., Moench T, Cone R. (2002) Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 29: 655-664.
29. Patton DL, Kidder GG, Sweeney Y.C., Rabe LK, Hillier S.L. (1999) Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol 180: 1080-1087.
30. Wisniewski JR, Zougman A, Nagaraj N., Mann M. (2009) Universal sample preparation method for proteome analysis. Nat Methods 6: 359-362.
31. Liu Y, Parman T, Schneider B., Song B, Galande AK, et al Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys. J Proteome Res 12: 1830-1837.
32. Redd AD, Mullis CE, Wendel S.K., Sheward D., Martens C, et al. (2014) Limited HIV-1 superinfection in seroconverters from the CAPRISA 004 Microbicide Trial. J Clin Microbiol 52: 844-848.
33. Galen BT, Martin AP, Hazrati E, Garin A., Guzman E, et al. (2007) A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. J Infect Dis 195: 1332-1339.
34. Roy S, Gourde P, Piret J., Desormeaux A, Lamontagne J, et al (2001) Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrob Agents Chemother 45: 1671-1681.
35. Catalone B, Kish-Catalone T, Budgeon L., Neely E, Ferguson M, et al (2004) Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob Agents Chemother 48: 1837-1847.
36. Fichorova RN, Yamamoto HS, Delaney M.L., Onderdonk AB, Doncel G.F. (2011) Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio 2: e00168-00111.
37. Wagner RD, Johnson S.J. (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19: 58.
38. Zalenskaya IA, Cerocchi OG, Joseph T, Donaghay M.A., Schriver SD, et al. (2011) Increased COX-2 Expression in Human Vaginal Epithelial Cells Exposed to Nonoxynol-9, a Vaginal Contraceptive Microbicide that Failed to Protect Women from HIV-1 Infection. American Journal of Reproductive Immunology 65: 569-577.
39. Fichorova R, Bajpai M, Chandra N., Hsiu J, Spangler M, et al (2004) Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod 71: 761-769.
40. Fichorova RN (2004) Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr 37 Suppl 3: S184-193.
41. Osanai A, Sashinami H, Asano K., Li S-J, Hu D-L, et al. (2011) Mouse Peptidoglycan Recognition Protein PGLYRP-1 Plays a Role in the Host Innate Immune Response against Listeria monocytogenes Infection. Infection and Immunity 79: 858-866.
42. Liu C, Gelius E, Liu G., Steiner H, Dziarski R. (2000) Mammalian Peptidoglycan Recognition Protein Binds Peptidoglycan with High Affinity, Is Expressed in Neutrophils, and Inhibits Bacterial Growth. Journal of Biological Chemistry 275: 24490-24499.
43. Liu C, Xu Z, Gupta D., Dziarski R. (2001) Peptidoglycan Recognition Proteins: A Novel Family of Four Human Innate Immunity Pattern Recognition Molecules. Journal of Biological Chemistry 276: 34686-34694.
44. Roy MG, Livraghi-Butrico A, Fletcher A.A., McElwee MM, Evans SE, et al. (2014) Muc5b is required for airway defence. Nature 505: 412-416.
45. Liu W, Yan M, Liu Y., Wang R, Li C, et al (2010) Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
46. Liu W, Yan M, Sugui J.A., Li H., Xu C, et al. (2013) Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease. The Journal of Clinical Investigation 123: 3751-3755.
47. Mulayim N, Palter SF, Kayisli U.A., Senturk L., Arici A. (2003) Chemokine receptor expression in human endometrium. Biol Reprod 68: 1491-1495.
48. Patterson BK, Landay A, Andersson J., Brown C, Behbahani H, et al (1998) Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 153: 481-490.
49. Kashyap DR, Wang M, Liu L.H., Boons GJ, Gupta D, et al. (2011) Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems. Nat Med 17: 676-683.
50. Lu X, Wang M, Qi J., Wang H, Li X, et al (2006) Peptidoglycan recognition proteins are a new class of human bactericidal proteins. J Biol Chem 281: 5895-5907.
51. Saha S, Qi J, Wang S., Wang M, Li X, et al (2009) PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation. Cell Host Microbe 5: 137-150.
52. Habte H, de Beer C, Lotz Z, Roux P., Mall A. (2010) Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts. Virology Journal 7: 269.
53. Park S-W, Zhen G., Verhaeghe C, Nakagami Y, Nguyenvu L.T., et al. (2009) The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proceedings of the National Academy of Sciences 106: 6950-6955.
54. Zhou Y, Shapiro M, Dong Q., Louahed J, Weiss C, et al (2002) A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Novartis Found Symp 248: 150-165; discussion 165-170, 277-182.
55. Ravel J, Gajer P, Fu L., Mauck CK, Koenig SS, et al. (2012) Twice-daily application of HIV microbicides alter the vaginal microbiota. M Bio 3.